<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02606435</url>
  </required_header>
  <id_info>
    <org_study_id>SEED</org_study_id>
    <nct_id>NCT02606435</nct_id>
  </id_info>
  <brief_title>Thrombus Aspiration in Patients With STEMI</brief_title>
  <official_title>Safety and Efficacy of Thrombus Aspiration in Patients With ST-segment Elevation Myocardial Infarction (STEMI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized study with blinded outcome assessment, comparing routine
      manual thrombus aspiration with no aspiration in patients with acute ST-segment elevation
      myocardial infarction (STEMI) underwent percutaneous coronary intervention (PCI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized study with blinded outcome assessment, comparing routine
      manual thrombus aspiration with no aspiration in patients with acute ST-segment elevation
      myocardial infarction (STEMI) underwent percutaneous coronary intervention (PCI). Patients
      who are diagnosed as STEMI and referred for PCI will be enrolled. They will be randomized 1:1
      to either manual thrombus aspiration with PCI group or PCI alone group.The primary outcome is
      the composite of cardiovascular death, recurrent myocardial infarction (MI), cardiogenic
      shock, stroke, new or worsening NYHA class IV heart failure during 1 year follow-up. The
      secondary efficacy outcome are stent thrombosis, target vessel revascularization, left
      ventricular function and quality of life during 1 year follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>1 year</time_frame>
    <description>number of participants with cardiovascular death, recurrent myocardial infarction (MI), cardiogenic shock, stroke, new or worsening NYHA class IV heart failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with stent thrombosis</measure>
    <time_frame>1 year</time_frame>
    <description>number of participants with stent thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with target vessel revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>number of participants with target vessel revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular function</measure>
    <time_frame>1 year</time_frame>
    <description>left ventricular ejection fraction evaluated by ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seattle Angina Questionnaire scores</measure>
    <time_frame>1 year</time_frame>
    <description>Seattle Angina Questionnaire scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk distance (6MWD)</measure>
    <time_frame>1 year</time_frame>
    <description>6-minute walk distance (6MWD)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>ST-segment Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>thrombus aspiration with PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient will receive manual thrombus aspiration with percutaneous coronary intervention (PCI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCI alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive percutaneous coronary intervention (PCI) alone including stent implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>percutaneous coronary intervention (PCI)</intervention_name>
    <description>percutaneous coronary intervention (PCI) by stent implantation</description>
    <arm_group_label>thrombus aspiration with PCI</arm_group_label>
    <arm_group_label>PCI alone</arm_group_label>
    <other_name>primary percutaneous coronary intervention (PCI)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>thrombus aspiration</intervention_name>
    <description>thrombus aspiration with export catheter</description>
    <arm_group_label>thrombus aspiration with PCI</arm_group_label>
    <other_name>export catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18-80;

          -  Diagnosed as STEMI for presenting symptoms or definite ECG and myocardial markers
             changes;

          -  Patients presenting with definite ECG changes indicating STEMI: ST elevation of 0.1 mV
             in 2 contiguous limb leads or ≥0.2 mV in 2 contiguous precordial leads;

          -  Referred for PCI for presenting symptoms, and the coronary angiogram (CAG) shows that
             the initial TIMI thrombus grade ≥2;

          -  Informed consent.

        Exclusion Criteria:

          -  Previous history of myocardiopathy, valvular heart disease or severe heart failure;

          -  Severe hepatic or renal dysfunction;

          -  Life expectancy less than 1 year;

          -  Prior PCI or CABG;

          -  Contraindications of using anticoagulation or antiplatelet drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongdong Sun, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fourth Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongdong Sun, M.D.,Ph.D.</last_name>
    <phone>86 29 84775183</phone>
    <email>wintersun3@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongdong Sun, M.D.,Ph.D</last_name>
      <phone>86 18691569930</phone>
      <email>wintersun3@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2015</study_first_submitted>
  <study_first_submitted_qc>November 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2015</study_first_posted>
  <last_update_submitted>November 12, 2015</last_update_submitted>
  <last_update_submitted_qc>November 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xijing Hospital</investigator_affiliation>
    <investigator_full_name>sunddong</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

